Patents by Inventor Jer-kang Chen
Jer-kang Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20150038368Abstract: A method, apparatus, or system for generating a pattern of polynucleotides on a substrate. The method includes providing a substrate having a hydrophobic surface. The method further includes conjugating a polystyrene moiety to a polynucleotide and applying a polystyrene-polynucleotide conjugate to create a plurality of reaction spots on the hydrophobic surface of the substrate. An apparatus includes a substrate with at least one polystyrene-polynucleotide conjugate on a surface of the substrate. A system can analyze a polystyrene-polynucleotide conjugate and the system may perform PCR.Type: ApplicationFiled: August 11, 2014Publication date: February 5, 2015Inventors: Timothy Z. LIU, Jer-Kang Chen, Ronald Graham
-
Publication number: 20140187429Abstract: Apparatus and methods for separating different polynucleotide populations in a mixture are provided, wherein different polynucleotides or polynucleotide populations are captured on different solid support. After hybridization, polynucleotides are selectively released from a selected support by altering a physical property of that support. The released polynucleotides can be eluted from a common flow path and isolated.Type: ApplicationFiled: January 3, 2014Publication date: July 3, 2014Applicant: Applied Biosystems, LLCInventors: John SHIGEURA, Jer-Kang CHEN
-
Patent number: 8058414Abstract: Nucleotide analogs that can sustain the enzymatic synthesis of double-stranded nucleic acid from a nucleic template are described. The nucleotide analogs include: (i) a base selected from the group consisting of adenine, guanine, cytosine, thymine, uracil and their analogs; (ii) a label attached to the base or analog of the base via a cleavable linker; (iii) a deoxyribose; and (iv) one or more phosphate groups. The linker and/or the label inhibits template directed polymerase incorporation of a further nucleotide substrate onto an extended primer strand. In addition, cleavage of the linker leaves a residue attached to the base which is not present in the natural nucleotide and which does not inhibit extension of the primer strand. The nucleotide analogs can therefore be used as reversible terminators in sequencing by synthesis methods without blocking the 3? hydroxyl group. Methods of sequencing DNA using the substrates are also described.Type: GrantFiled: January 16, 2009Date of Patent: November 15, 2011Assignee: Life Technologies CorporationInventors: Steven Menchen, Barnett Rosenblum, Paul Kenney, Shoeb Khan, Zhaochun Ma, Jer-Kang Chen, Joe Y. Lam, Boli Huang
-
Publication number: 20110143343Abstract: Ligation-based methods and kits are disclosed for determining the degree of methylation of one or more target nucleotides. In certain embodiments, the methylation status of one or more target nucleotides is determined by generating misligation products. In certain embodiments, at least one target nucleotide is amplified prior to the ligation reaction. In certain embodiments, at least one ligation product, at least one ligation product surrogate, at least one misligation product, at least one misligation product surrogate, or combinations thereof are amplified. In certain embodiments, one or more ligation probes comprise at least one nucleotide analog, at least one Modification, at least one mismatched nucleotide, or combinations thereof.Type: ApplicationFiled: July 26, 2010Publication date: June 16, 2011Applicant: Applied Biosystems, LLCInventors: MARK R. ANDERSEN, JER-KANG CHEN, MICHAEL W. HUNKAPILLER, STEVEN M. MENCHEN
-
Publication number: 20090308736Abstract: Apparatus and methods for separating different polynucleotide populations in a mixture are provided, wherein different polynucleotides or polynucleotide populations are captured on different solid support. After hybridization, polynucleotides are selectively released from a selected support by altering a physical property of that support. The released polynucleotides can be eluted from a common flow path and isolated.Type: ApplicationFiled: March 9, 2009Publication date: December 17, 2009Applicant: LIFE TECHNOLOGIES CORPORATION, a Delaware CorporationInventors: Janice G. Shigeura, Jer-Kang Chen, John Shigeura
-
Publication number: 20090269759Abstract: Nucleotide analogs that can sustain the enzymatic synthesis of double-stranded nucleic acid from a nucleic template are described. The nucleotide analogs include: (i) a base selected from the group consisting of adenine, guanine, cytosine, thymine, uracil and their analogs; (ii) a label attached to the base or analog of the base via a cleavable linker; (iii) a deoxyribose; and (iv) one or more phosphate groups. The linker and/or the label inhibits template directed polymerase incorporation of a further nucleotide substrate onto an extended primer strand. In addition, cleavage of the linker leaves a residue attached to the base which is not present in the natural nucleotide and which does not inhibit extension of the primer strand. The nucleotide analogs can therefore be used as reversible terminators in sequencing by synthesis methods without blocking the 3? hydroxyl group. Methods of sequencing DNA using the substrates are also described.Type: ApplicationFiled: January 16, 2009Publication date: October 29, 2009Applicant: LIFE TECHNOLOGIESInventors: Steven M. Menchen, JR., Barnett Rosenblum, Paul Kenney, Shoeb I. Khan, Zhaochun Ma, Jer-Kang Chen, Joe Lam, Boli Huang
-
Publication number: 20090186779Abstract: An array comprising a probe covalently attached to a diamond substrate is fabricated, for example, by treating the diamond substrate with an aryl diazonium compound and covalently attaching the probe to the aryl group. Some embodiments are useful in DNA-based sensing applications.Type: ApplicationFiled: April 3, 2009Publication date: July 23, 2009Applicant: Applera CorporationInventors: Timothy Z. Liu, Timothy Woudenberg, Jer-Kang Chen
-
Publication number: 20090142761Abstract: Ligation-based methods and kits are disclosed for determining the degree of methylation of one or more target nucleotides. In certain embodiments, the methylation status of one or more target nucleotides is determined by generating misligation products. In certain embodiments, at least one target nucleotide is amplified prior to the ligation reaction. In certain embodiments, at least one ligation product, at least one ligation product surrogate, at least one misligation product, at least one misligation product surrogate, or combinations thereof are amplified. In certain embodiments, one or more ligation probes comprise at least one nucleotide analog, at least one Modification, at least one mismatched nucleotide, or combinations thereof.Type: ApplicationFiled: April 28, 2008Publication date: June 4, 2009Applicant: Applera CorporationInventors: Mark R. Andersen, Jer-Kang Chen, Michael W. Hunkapiller, Steven M. Menchen
-
Patent number: 7501284Abstract: Apparatus and methods for separating different polynucleotide populations in a mixture are provided, wherein different polynucleotides or polynucleotide populations are captured on different solid support. After hybridization, polynucleotides are selectively released from a selected support by altering a physical property of that support. The released polynucleotides can be eluted from a common flow path and isolated.Type: GrantFiled: July 17, 2001Date of Patent: March 10, 2009Assignee: Applera CorporationInventors: John Shigeura, Jer-Kang Chen
-
Publication number: 20080268440Abstract: A method, apparatus, or system for generating a pattern of polynucleotides on a substrate. The method includes providing a substrate having a hydrophobic surface. The method further includes conjugating a polystyrene moiety to a polynucleotide and applying a polystyrene-polynucleotide conjugate to create a plurality of reaction spots on the hydrophobic surface of the substrate. An apparatus includes a substrate with at least one polystyrene-polynucleotide conjugate on a surface of the substrate. A system can analyze a polystyrene-polynucleotide conjugate and the system may perform PCR.Type: ApplicationFiled: April 26, 2007Publication date: October 30, 2008Inventors: Timothy Z. Liu, Jer-Kang Chen, Ronald J. Graham
-
Patent number: 7364855Abstract: Ligation-based methods and kits are disclosed for determining the degree of methylation of one or more target nucleotides. In certain embodiments, the methylation status of one or more target nucleotides is determined by generating misligation products. In certain embodiments, at least one target nucleotide is amplified prior to the ligation reaction. In certain embodiments, at least one ligation product, at least one ligation product surrogate, at least one misligation product, at least one misligation product surrogate, or combinations thereof are amplified. In certain embodiments, one or more ligation probes comprise at least one nucleotide analog, at least one Modification, at least one mismatched nucleotide, or combinations thereof.Type: GrantFiled: May 2, 2005Date of Patent: April 29, 2008Assignee: Applera CorporationInventors: Mark R. Andersen, Jer-Kang Chen, Michael W. Hunkapiller, Steven M. Menchen
-
Publication number: 20080091005Abstract: Modified nucleotides are disclosed for use in single molecule sequencing, methods for making the modified nucleotides and method for using the modified nucleotides. Linkers for making the modified nucleotide are also disclosed.Type: ApplicationFiled: July 20, 2007Publication date: April 17, 2008Applicants: VISIGEN BIOTECHNOLOGIES, INC., APPLIED BIOSYSTEMSInventors: Hongyi Wang, Xiaolian Gao, Peilin Yu, Mitsu Reddy, Susan Hardin, Tommie Lincecum, Amy Williams, Norha Deluge, Yuri Belosludtsev, Steven Menchen, Joe Lam, Jer-Kang Chen
-
Publication number: 20050266458Abstract: Ligation-based methods and kits are disclosed for determining the degree of methylation of one or more target nucleotides. In certain embodiments, the methylation status of one or more target nucleotides is determined by generating misligation products. In certain embodiments, at least one target nucleotide is amplified prior to the ligation reaction. In certain embodiments, at least one ligation product, at least one ligation product surrogate, at least one misligation product, at least one misligation product surrogate, or combinations thereof are amplified. In certain embodiments, one or more ligation probes comprise at least one nucleotide analog, at least one Modification, at least one mismatched nucleotide, or combinations thereof.Type: ApplicationFiled: May 2, 2005Publication date: December 1, 2005Applicant: Applera CorporationInventors: Mark Andersen, Jer-Kang Chen, Michael Hunkapiller, Steven Menchen
-
Publication number: 20050019803Abstract: Disclosed herein is an array patterned on an electrode and a method for fabricating the same. The array comprises a probe covalently attached to the electrode through a coupling group, an attachment group, and an aryl group.Type: ApplicationFiled: June 12, 2004Publication date: January 27, 2005Inventors: Timothy Liu, Timothy Woudenberg, Jer-Kang Chen
-
Patent number: 6638760Abstract: The present invention provides substrates and apparatuses for efficient, rapid and specific capture, and optimal recovery, of nucleic acids, as well as methods of their use. The substrate is porous in nature and has a capture polynucleotide capable of hybridizing to a target nucleic acid immobilized thereon. Upon flowing a sample containing or suspected of containing the target nucleic acid through the porous substrate, the target nucleic acid is rapidly captured. Following capture, the target nucleic acid can be efficiently recovered for subsequent use.Type: GrantFiled: December 3, 1998Date of Patent: October 28, 2003Assignee: PE Corporation (NY)Inventors: Jer-Kang Chen, Claudia Chiesa, George A. Fry, Vergine C. Furniss, Stephen M. Lambert, Roger O'Neill, Majid Mehrpouyan
-
Patent number: 6514699Abstract: The invention relates to methods and compositions for simultaneously generating a plurality of polynucleotide sequencing ladders or PCR amplification products. Each sequencing ladder is generated from a recoverable primer, i.e., an oligonucleotide primer comprising a recovery tag. The recovery tag may be an oligonucleotide. Each sequencing ladder has a unique recovery tag. After the generation of the multiple sequencing ladders, the different sequencing ladders are separated from one another, i.e., purified, by binding to recovery tag binding compounds that have been immobilized on one or more solid supports. The recovery tag binding compounds are immobilized on the solid support in an addressable manner, i.e., the recovery tag binding compounds have distinct locations on the solid support. The binding of the sequencing ladders to the recovery tag binding compounds serves to separate the different polynucleotide sequencing ladders present in a given solution.Type: GrantFiled: June 13, 2000Date of Patent: February 4, 2003Assignee: PE Corporation (NY)Inventors: Roger A. O'Neill, Jer-Kang Chen, Claudia Chiesa, George Fry
-
Publication number: 20020076718Abstract: Apparatus and methods for separating different polynucleotide populations in a mixture are provided, wherein different polynucleotides or polynucleotide populations are captured on different solid support. After hybridization, polynucleotides are selectively released from a selected support by altering a physical property of that support. The released polynucleotides can be eluted from a common flow path and isolated.Type: ApplicationFiled: July 17, 2001Publication date: June 20, 2002Inventors: John Shigeura, Jer-Kang Chen
-
Patent number: 6169170Abstract: Modified oligonucleotides 3′-NHP(O)(O−)O-5′ phosphoramidates were synthesized on a solid phase support. The phosphoramidate analogs were found to have significantly increased resistance toward phosphodiesterase digestion. Thermal dissociation experiments demonstrated that these compounds form more stable duplexes than phosphodiesters with complementary DNA and particularly RNA strands. Further, the phosphoramidate analogs can also form stable triplexes with double-stranded DNA target, where under similar conditions parent phosphodiester compounds failed to do so.Type: GrantFiled: September 3, 1997Date of Patent: January 2, 2001Assignee: Lynx Therapeutics, Inc.Inventors: Sergei M. Gryaznov, Ronald G. Schultz, Jer-kang Chen
-
Patent number: 6124092Abstract: The invention relates to methods and compositions for simultaneously generating a plurality of polynucleotide sequencing ladders or PCR amplification products. Each sequencing ladder is generated from a recoverable primer, i.e., an oligonucleotide primer comprising a recovery tag. The recovery tag may be an oligonucleotide. Each sequencing ladder has a unique recovery tag. After the generation of the multiple sequencing ladders, the different sequencing ladders are separated from one another, i.e., purified, by binding to recovery tag binding compounds that have been immobilized on one or more solid supports. The recovery tag binding compounds are immobilized on the solid support in an addressable manner, i.e., the recovery tag binding compounds have distinct locations on the solid support. The binding of the sequencing ladders to the recovery tag binding compounds serves to separate the different polynucleotide sequencing ladders present in a given solution.Type: GrantFiled: June 12, 1997Date of Patent: September 26, 2000Assignee: The Perkin-Elmer CorporationInventors: Roger A. O'Neill, Jer-Kang Chen, Claudia Chiesa, George Fry
-
Patent number: 5965720Abstract: Modified oligonucleotides 3'-NHP(O)(O.sup.-)O-5' phosphoramidates were synthesized on a solid phase support. The phosphoramidate analogs were found to have significantly increased resistance toward phosphodiesterase digestion. Thermal dissociation experiments demonstrated that these compounds form more stable duplexes than phosphodiesters with complementary DNA and particularly RNA strands. Further, the phosphoramidate analogs can also form stable triplexes with double-stranded DNA target, where under similar conditions parent phosphodiester compounds failed to do so.Type: GrantFiled: January 10, 1997Date of Patent: October 12, 1999Assignee: Lynx Therapeutics, Inc.Inventors: Sergei M. Gryaznov, Ronald G. Schultz, Jer-kang Chen